Drug repurposing using computational methods to identify therapeutic options for COVID-19

Soodeh Mahdian; Azadeh Ebrahim‐Habibi; Mahboobeh Zarrabi

doi:10.1007/s40200-020-00546-9

ScienceGate Book Chapters

JOURNAL ARTICLE

Drug repurposing using computational methods to identify therapeutic options for COVID-19

Soodeh Mahdian Azadeh Ebrahim‐Habibi Mahboobeh Zarrabi

Year: 2020 Journal: Journal of Diabetes & Metabolic Disorders Vol: 19 (2)Pages: 691-699 Publisher: Springer Nature

DOI: 10.1007/s40200-020-00546-9

Get Full-Text PDF Get Analytical Report

Keywords:

Drug repositioning Simeprevir Virtual screening Repurposing Drug Protease Virology Ledipasvir Pharmacology Coronavirus Coronavirus disease 2019 (COVID-19) Drug discovery Computational biology Chemistry Medicine Biology Virus Bioinformatics Biochemistry Infectious disease (medical specialty) Enzyme

Metrics

Cited By

10.00

FWCI (Field Weighted Citation Impact)

Refs

0.98

Citation Normalized Percentile

Is in top 1%

Is in top 10%

Citation History

Topics

Computational Drug Discovery Methods

Physical Sciences → Computer Science → Computational Theory and Mathematics

Pharmacological Effects of Natural Compounds

Life Sciences → Pharmacology, Toxicology and Pharmaceutics → Pharmacology

SARS-CoV-2 and COVID-19 Research

Health Sciences → Medicine → Infectious Diseases

Drug repurposing using computational methods to identify therapeutic options for COVID-19

Metrics

Citation History

Topics

Related Documents

Drug Repurposing for COVID-19 using Computational Methods

Computational-based drug repurposing methods in COVID-19

A Network-Biology Led Computational Drug Repurposing Strategy to Prioritize Therapeutic Options for COVID-19

A network-biology led computational drug repurposing strategy to prioritize therapeutic options for COVID-19

Therapeutic Options for COVID-19: Drug Repurposing of Serine Protease Inhibitor Against TMPRSS2